Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

doi:10.3748/wjg.v25.i38.5883

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5963)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

459

WORD

195

HTML

2738

Figures (1-6)

346

Tables (1-2)

258

Sum=3996

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

628

Download

1339

Sum=1967

Oct 14, 2019 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 14, 2019; 25(38): 5883-5896
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5883

Full Size Figure Download Figure

Figure 3 Analysis of basal core promoter/precore/core region mutants related with the hepatocellular carcinoma risk. A: Frequency distribution of BCP/precore/core and HBsAg mutations (Black, grey and white bars show the viral variants with the highest, median and lowest evidences of association with HCC, respectively); B: Sequences of the 7 patients with preS deletions. BCP: Basal core promoter; HCC: Hepatocellular carcinoma.

Citation: Gil-García AI, Madejón A, Francisco-Recuero I, López-López A, Villafranca E, Romero M, García A, Olveira A, Mena R, Larrubia JR, García-Samaniego J. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment. World J Gastroenterol 2019; 25(38): 5883-5896
URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5883.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5883